Proposed Sale And Purchase Of A Piece Of Land Situated In Pt 8839 Mukim Bukit Baru, District Of Melaka Tengah, State Of Melaka Measuring An Area Of Approximately 24.78 Acres (“Proposed Sale And Purchase”) Which Is For The Purpose Of Proposed Development Of Melaka Lifecare Specialist With Estimated Rm1.6 Billion Gross Development Value (GDV) [1 April 2021] Press Release

1 April 2021, Melaka, Malaysia : Nexgram Biomedic Sdn Bhd, an indirect subsidiary of Nexgram Holdings Berhad (“Nexgram”), a company listed on the ACE Market of Bursa Malaysia Securities Berhad, today have digitally signed an understanding with Perbadanan Kemajuan Negeri Melaka (PKNM) at its  50th anniversary celebration in relation to the proposed sale and purchase of a piece of land situated in PT 8839 Mukim Bukit Baru, District of Melaka Tengah, State of Melaka measuring an area of approximately 24.78 acres (“Said Land”). The proposed acquisition of the Said Land is proposed to be developed as Melaka Lifecare Specialist Project which the proposed gross development value estimated at RM1.6 billion

The event is witnessed by Melaka Chief Minister YAB Datuk Seri Utama (Dr) Haji Sulaiman Md Ali. The proposed acquisition of the land will be dedicated for mix development comprising hospital building, service SOHO (annexed to the Hospital), Wellness Centre & Bioscience Research Centre, Retirement & Medical Tourism (annexed to the Wellness Centre), MM2H Program (annexed to the Wellness Centre), 3 Star Hotel & Condotel, and Commercial and Recreation Park.

This public private cooperation initiative is in line with the government push for technology-based investments which can in turn raise the knowledge and digital economic capability and capacity level of Malaysians. Melaka is well poised for this with its excellent economy and social growth dynamics. 

This super specialty medical complex is expected to serve the Healthcare needs of the wider Asian region. 

The mix development is expected to contribute positively to state of Melaka economic GDP, employment and social welfare and prosperity within the next 5 to 10 years.

About Nexgram Biomedic Sdn Bhd

NEXGRAM BIOMEDIC GROUP is a global bio technology company dedicated to develop new medical devices, drugs, and technologies in support of innovations in the Healthcare field. The group subsidiaries include Medical Brands and Tri-G Technologies specialising in medical devices; VaccinesLab which conduct clinical trial and vaccine distribution; data science company MDS which develops Covid-19 screening test and vaccine record tracking App using electronic health certificates (E-Certs) powered by Tracvirus Open Platform; NMed Industries which trade, distribute and invest in medical device and personal protection equipment manufacturing; Arita Group, the specialist in Acrylic medical devices material and vaccine bottling manufacturer; as well as Glove Alliance specialising in medical and disposable nitrile gloves end-to-end supply chain. 

Officiated recently by the Prime Minister of Malaysia, TracAPM is the official Malaysia Civil Defence Force (APM) digital system provider. Angkatan Pertahanan Malaysia (APM) is entrusted by the National Security Council (MKN) to manage travellers at all national entry points. TracAPM is powered by Tracvirus Open Digital Platform, and travelers can book for SafeTravelPass at official portal https://safetravelpass.tracvirus.com.my to experience contactless verification process in Kuala Lumpur International Airport (KLIA). The portal currently supports 8 international languages. This digital verification capability can be used to verify vaccine passports for International travel.